Exploratory investigation of changes in blood transcriptome following mepolizumab treatment for asthma

• by Mitchell Pitlick, Mrunal K. Dehankar, Chantal E. McCabe, Sergio E. Chiarella, Kathleen Bartemes, Kay A. Bachman, Chung-Il Wi, Young J. Juhn, Thanai Pongdee

• June 15, 2026

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.

• by Kathryn Wighton

• May 29, 2026

• 3 min

Melatonin suppresses ILC2-driven airway hyperreactivity via glutathione-dependent metabolic reprogramming

• by Jafar Cain, Benjamin P. Hurrell, Stephen Shen, Paul Speliakos, Omid Akbari

• May 11, 2026

Measles Renews Focus on Vaccine Waivers

“And when one of these measles cases ends up in a low-immunization community, that's when the ember really has a chance to expand and become a wildfire.”

• by Kate Wells

• June 3, 2026

• 10 min